<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04854564</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-300007058</org_study_id>
    <nct_id>NCT04854564</nct_id>
  </id_info>
  <brief_title>Identifying Perceived Barriers and Facilitators Toward a Liver Transplantation Prehabilitation</brief_title>
  <official_title>Identifying Perceived Barriers and Facilitators to Inform the Development of a Liver Transplantation Prehabilitation Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to formally identify patient and caregiver perceived needs,&#xD;
      barriers, and facilitators to inform the development of a home-based multimodal&#xD;
      prehabilitation program for potential LT candidates.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After being informed about the study and potential risks, all participants (patients and&#xD;
      caregivers) giving written informed consent will be invited to participate in one of three&#xD;
      research activities: interviews (n=10), nominal group technique meetings (n=64), or&#xD;
      card-sorting and rating survey (n=40).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Liver frailty index (LFI) score</measure>
    <time_frame>From baseline through 3 months</time_frame>
    <description>Change from baseline in liver frailty index score at 3 months; the higher LFI scores indicate a higher degree of frailty. LFI&lt;3.2: robust, LFI=3.2-4.4: prefrail, LFI&gt;=4.5: Frail.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Caregiver burden measured using Zarit Burden Interview short form (ZBI-12)</measure>
    <time_frame>From baseline through 3 months</time_frame>
    <description>Change from baseline in the total ZBI-12 scores at 3 months. The total ZBI-12 score is the summation of 12 items, ranging from 0 to 48; the higher scores indicate higher burden (0-10:no to mild burden; 10-20: mild to moderate burden), and &gt;20: high burden.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">114</enrollment>
  <condition>Liver Transplant; Complications</condition>
  <arm_group>
    <arm_group_label>End-stage liver disease (ESLD) patients</arm_group_label>
    <description>These potential liver transplant candidates are patients with end-stage liver disease (ESLD) who have been assigned to the liver transplant waitlist.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Caregivers of potential liver transplant candidates</arm_group_label>
    <description>They are the primary caregivers for the patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Prehabilitation intervention</intervention_name>
    <description>The investigators will identify participants' perceived important information to develop a prehabilitation intervention in this study. Prehabilitation intervention consisting of physical activities, nutrition, and stress management.</description>
    <arm_group_label>End-stage liver disease (ESLD) patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Caregiver intervention</intervention_name>
    <description>The investigators will provide caregivers with variety of educational resources for patients experiencing ESLD.</description>
    <arm_group_label>Caregivers of potential liver transplant candidates</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This study will include adult, all gender, and all race patients with end-stage liver&#xD;
        disease (ESLD) who have been assigned to the liver transplant (LT) waitlist. Nationally,&#xD;
        the median age of LT candidates is 57 (48, 63) during 2014 to 2018. UAB Liver Transplant&#xD;
        Center technically does not limit patients over 75 years old for LT (i.e., age alone is not&#xD;
        an absolute contraindication), but typically as patients age they have less physiologic&#xD;
        reserve to tolerate transplant so they must have a better pre-transplant functional status&#xD;
        than a younger patient in order to have a good outcome post-transplant. Participants will&#xD;
        be identified and recruited from the UAB Liver Transplant Center using a purposive maximum&#xD;
        variation sampling approach in terms of age, gender, race, and severity of ESLD.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Liver transplant (LT) candidates are:&#xD;
&#xD;
          -  Adult ESLD patients (age=19-74 years) who are assigned to the LT waitlist&#xD;
&#xD;
          -  English-speaking&#xD;
&#xD;
          -  No contraindication to moderate intensity physical activities&#xD;
&#xD;
          -  Physician clearance for participation in moderate intensity physical activities&#xD;
&#xD;
          -  No history of dementia or organic brain syndrome&#xD;
&#xD;
        Caregivers:&#xD;
&#xD;
          -  Adult (ageâ‰¥ 19 years)&#xD;
&#xD;
          -  English-speaking&#xD;
&#xD;
          -  Provide direct care to LT candidates&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to communicate verbally in English&#xD;
&#xD;
          -  Documentation of cognitive deficits&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Haiyan Qu, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Haiyan Qu, PhD</last_name>
    <phone>(205) 934-6101</phone>
    <email>haiyanqu@uabmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rhiannon D Reed, DrPH</last_name>
    <phone>(205) 996-2894</phone>
    <email>rdeierhoi@uabmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haiyan Qu, PhD</last_name>
      <phone>205-934-6101</phone>
      <email>haiyanqu@uabmc.edu</email>
    </contact>
    <investigator>
      <last_name>Haiyan Qu, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>April 13, 2021</study_first_submitted>
  <study_first_submitted_qc>April 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 22, 2021</study_first_posted>
  <last_update_submitted>August 9, 2021</last_update_submitted>
  <last_update_submitted_qc>August 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Haiyan Qu</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>end-stage liver disease (ESLD)</keyword>
  <keyword>frailty</keyword>
  <keyword>prehabilitation</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The nominal group technique meeting data will be shared in an aggregate level by group. The card-sorting data and rating data will be shared in an aggregate level by participant type (patient vs caregiver).</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

